Talastine (Ahanon) as a cause of allergic drug exanthema
Richter, G.; Kühn, E.
Dermatologische Monatschrift 176(2-3): 111-113
1990
ISSN/ISBN: 0011-9083 PMID: 1973126 Document Number: 361339
Described are two drug eruptions from talastine hydrochloride (Ahanon). To the best of our knowledge these are the first published allergic exanthemas due to this antihistamine.
Document emailed within 1 workday
Related Documents
Lindemayr, W.; Partsch, H. 1970: Drug-induced exanthema Wiener Klinische Wochenschrift 82(26): 473-478Stubb, S. 1976: Blood leukocytes, with special reference to basophils and eosinophils, during provocation tests in fixed eruption and drug exanthema Acta Dermato-Venereologica. Supplementum 56(76): 1-47
Rzany, B.; Mockenhaupt, M.; Baur, S.; Stocker, U.; Schöpf, E. 1993: Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 44(8): 549-54; Quiz 554-6
Cohen, P.R. 2015: Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid Dermatology Online Journal 21(8)
Goerz, G.; Merk, H. 1980: Non-allergic drug exanthemas Fortschritte der Medizin 98(19): 726-730
Turner, P. 1987: Terfenadine: an anti-allergic drug British Journal of Clinical Practice 41(7): 814-815
Loucopoulos, N.; Gellis, D.; Gkeles, D. 1974: Allergic drug reactions in dentistry Stomatologia 31(2): 105-117
Schulz, K.H. 1971: Allergic drug injuries of the skin Zeitschrift für Allgemeinmedizin 47(9): 451-456
Hajós, M. 1971: A new antihistaminic drug (Tavegyl) in allergic diseases Therapia Hungarica 19(2): 67-69
Griffin, J.P. 1983: Drug-induced allergic and hypersensitivity reactions Practitioner 227(1382): 1283-1297
Shellenberger, M.K. 1982: Drug interactions in therapy of allergic patients Comprehensive Therapy 8(3): 35-39
Kleinsorge, H. 1970: Pathogenesis and diagnosis of allergic drug reactions Die Medizinische Welt 35: 1497-1505
Kasckow, J.W.; Tabira, T.; Itoyama, Y.; Kuroiwa, Y.; Takenaka, A.; Nagai, Y. 1981: Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug Japanese Journal of Experimental Medicine 51(5): 293-298
Cremer, L.; Avram, D.; Călugăru, A.; Szegli, G.; Radu, J.R.; Herold, A. 2001: Anti-inflammatory non-steroidal drug able to modulate IL-10 in allergic asthma Roumanian Archives of Microbiology and Immunology 60(1): 17-25
Girard, J.P.; Cattin, S.; Cuevas, M. 1976: Immunological mechanisms and diagnostic tests in allergic drug reactions Annals of Clinical Research 8(2): 74-84
Zetterström, O.; Michaëlsson, G. 1972: Drug color-additive induced asthma in an aspirin-allergic patient Lakartidningen 69(38): 4178-4179
Mauri-Hellweg, D.; Bettens, F.; Mauri, D.; Brander, C.; Hunziker, T.; Pichler, W.J. 1995: Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine Journal of Immunology 155(1): 462-472
Budagovskaia, V.N.; Voĭtko, N.E. 1984: Allergic reactions in patients with peptic ulcer; incidence of food and drug allergy Voprosy Pitaniia 3: 30-33
Vacher, D.; Aumaître, O.; Mignot, P.; Lavarenne, J.; Molina, C. 1987: Drug-induced allergic alveolitis and Parsonage-Turner syndrome in a patient treated with labetalol Presse Medicale 16(11): 539-540
Bock, H.E.; Hartl, W.; Genth, E. 1970: In vitro binding of complement on leukocytes. Contribution to the immunopathogenesis of Schultz's drug allergic agranulocytosis Schweizerische Medizinische Wochenschrift 100(14): 617-622